Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Study - A Primarily Prospective Observational Study of COVID-19 Clinical Characteristics and Acquired Immune Response Within the General Population

NCT04348942 is registered in ClinicalTrials.gov with ObvioHealth as lead sponsor.

NCT NCT04348942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04348942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Study - A Primarily Prospective Observational Study of COVID-19 Clinical Characteristics and Acquired Immune Response Within the General Population
Lead sponsor
ObvioHealth
Phase
Observational
Overall status
Completed
Start date
May 29, 2020
Completion date
March 21, 2021
Enrollment
804 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19